Fresh Recalls

QuVa Pharma recalls

Recall found. QuVa Pharma is named in FDA Class II recall D-0664-2026 covering Methohexital Sodium. Hazard: Failed Impurities/Degradation Specifications Identifying details: Lot #: 10162261, 10162262, 10162279, 10162280, Exp. Date 07/21/2026; 10162314, 10162315, Exp. Date 07/22/2026; 10162465, 10162466, 10162491, 10162492, Exp. Date 07/26/2026; 10162542, 10162543, Exp. Date 07/27/2026; 10162559, 10162560, Exp. Date 07/28/2026; 10162623, 10162624, Exp. Date 07/29/2026; 10162693, 10162694, Exp. Date 07/30/2026; 10162735, 10162736, 10162753, 10162754, Exp. Date 07/31/2026; 10162772, 10162773, 10162791, 10162792, 10162810, 10162811, Exp. Date 08/02/2026; 10162820, Exp. Date 08/03/2026; 10162853, 10162854, Exp. Date 08/04/2026; 10163046, Exp. Date 08/09/2026; 10163156, 10163157, Exp. Date 08/10/2026.. Status: Ongoing.

Models with recalls

Methohexital Sodium (1)

All QuVa Pharma recalls

FDA Class II · Drug · July 15, 2026

Methohexital Sodium recall — QuVa Pharma, Inc.

Failed Impurities/Degradation Specifications

Official ID D-0664-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked September 7, 2026 at 6:00 AM UTC.